NO305125B1 - Farmas°ytiske forbindelser - Google Patents
Farmas°ytiske forbindelserInfo
- Publication number
- NO305125B1 NO305125B1 NO931917A NO931917A NO305125B1 NO 305125 B1 NO305125 B1 NO 305125B1 NO 931917 A NO931917 A NO 931917A NO 931917 A NO931917 A NO 931917A NO 305125 B1 NO305125 B1 NO 305125B1
- Authority
- NO
- Norway
- Prior art keywords
- alkyl
- pharmaceutical compounds
- optionally substituted
- cycloalkyl
- alkyl groups
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 4
- 125000000008 (C1-C10) alkyl group Chemical group 0.000 abstract 1
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 abstract 1
- 125000006374 C2-C10 alkenyl group Chemical group 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 125000000304 alkynyl group Chemical group 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 125000001475 halogen functional group Chemical group 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Addiction (AREA)
- Anesthesiology (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB929211379A GB9211379D0 (en) | 1992-05-29 | 1992-05-29 | Pharmaceutical compounds |
| GB939309025A GB9309025D0 (en) | 1993-04-30 | 1993-04-30 | Pharmaceutical compounds |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO931917D0 NO931917D0 (no) | 1993-05-26 |
| NO931917L NO931917L (no) | 1993-11-30 |
| NO305125B1 true NO305125B1 (no) | 1999-04-06 |
Family
ID=26300951
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO931917A NO305125B1 (no) | 1992-05-29 | 1993-05-26 | Farmas°ytiske forbindelser |
Country Status (21)
| Country | Link |
|---|---|
| EP (1) | EP0582368B1 (cs) |
| JP (1) | JP3219541B2 (cs) |
| CN (1) | CN1043994C (cs) |
| AT (1) | ATE198891T1 (cs) |
| AU (1) | AU668159B2 (cs) |
| CA (1) | CA2097016A1 (cs) |
| CZ (1) | CZ282783B6 (cs) |
| DE (1) | DE69329887T2 (cs) |
| DK (1) | DK0582368T3 (cs) |
| ES (1) | ES2153373T3 (cs) |
| FI (1) | FI101538B1 (cs) |
| GR (1) | GR3035587T3 (cs) |
| HU (1) | HU218278B (cs) |
| IL (1) | IL105827A (cs) |
| MX (1) | MX9303124A (cs) |
| MY (1) | MY109943A (cs) |
| NO (1) | NO305125B1 (cs) |
| NZ (1) | NZ247703A (cs) |
| PT (1) | PT582368E (cs) |
| RU (1) | RU2125574C1 (cs) |
| TW (1) | TW268005B (cs) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5457101A (en) * | 1994-06-03 | 1995-10-10 | Eli Lilly And Company | Thieno[1,5]benzoidiazepine use |
| US5574028A (en) * | 1994-10-31 | 1996-11-12 | Eli Lilly And Company | Method for treating anxiety |
| EG23659A (en) * | 1995-03-24 | 2007-03-26 | Lilly Co Eli | Process and crystal forms of methyl-thieno-benzodiazepine |
| CR5278A (es) * | 1995-03-24 | 1996-07-04 | Lilly Co Eli | Formulacion oral de 2-metil-tieno-benzodiacepina |
| EG24221A (en) * | 1995-03-24 | 2008-11-10 | Lilly Co Eli | Process for preparing olanzapine |
| US5891461A (en) * | 1995-09-14 | 1999-04-06 | Cygnus, Inc. | Transdermal administration of olanzapine |
| AU721290B2 (en) * | 1996-03-25 | 2000-06-29 | Eli Lilly And Company | Method for treating migraine pain |
| IL126203A (en) * | 1996-03-25 | 2002-12-01 | Lilly Co Eli | A synergistic painkiller that contains olenzapine and another painkiller |
| JP2001517202A (ja) * | 1996-03-25 | 2001-10-02 | イーライ・リリー・アンド・カンパニー | 痛み処置方法 |
| RS49597B (sr) | 1996-09-23 | 2007-06-04 | Eli Lilly And Company, | Olanzapin dihidrat d |
| ZA978515B (en) * | 1996-09-23 | 1999-03-23 | Lilly Co Eli | Intermediates and process for preparing olanzapine |
| WO1998013027A1 (en) * | 1996-09-24 | 1998-04-02 | Eli Lilly And Company | Coated particle formulation |
| RU2185383C1 (ru) * | 2001-05-22 | 2002-07-20 | Институт молекулярной генетики РАН | ВЫСОКОМЕЧЕННЫЙ ТРИТИЕМ 2-МЕТИЛ-4-(4-МЕТИЛ-1-ПИПЕРАЗИНИЛ)-10Н-ТИЕНО[2,3-b][1,5]БЕНЗОДИАЗЕПИН |
| PL2888590T3 (pl) | 2012-08-21 | 2020-11-30 | Janssen Pharmaceutica Nv | Przeciwciała dla olanzapiny i ich zastosowanie |
| PL3415516T3 (pl) | 2012-08-21 | 2022-03-28 | Janssen Pharmaceutica Nv | Hapteny rysperydonu i paliperydonu |
| ES2666000T3 (es) | 2012-08-21 | 2018-04-30 | Janssen Pharmaceutica, N.V. | Anticuerpos para aripiprazol y uso de los mismos |
| EP2888287A4 (en) | 2012-08-21 | 2016-04-20 | Ortho Clinical Diagnostics Inc | ANTIBODIES AGAINST PALIPERIDONE HAPTENES AND THEIR USE |
| ES2926662T3 (es) | 2012-08-21 | 2022-10-27 | Janssen Pharmaceutica Nv | Anticuerpos contra haptenos de risperidona y uso de los mismos |
| AU2013305935B2 (en) | 2012-08-21 | 2017-08-24 | Saladax Biomedical Inc. | Haptens of quetiapine for use in immunoassays |
| CN110054693A (zh) | 2012-08-21 | 2019-07-26 | 詹森药业有限公司 | 喹硫平半抗原的抗体及其用途 |
| WO2014031587A1 (en) * | 2012-08-21 | 2014-02-27 | Janssen Pharmaceutica Nv | Haptens of olanzipine |
| EP3581195B1 (en) | 2012-08-21 | 2025-10-01 | Janssen Pharmaceutica NV | Antibodies to olanzapine haptens and use thereof |
| US9504682B2 (en) | 2012-08-21 | 2016-11-29 | Janssen Pharmaceutica Nv | Haptens of aripiprazole |
| US9465041B2 (en) | 2012-08-21 | 2016-10-11 | Janssen Pharmaceutica Nv | Antibodies to paliperidone and use thereof |
| WO2014031635A1 (en) | 2012-08-21 | 2014-02-27 | Ortho-Clinical Diagnostics, Inc | Antibodies to aripiprazole haptens and use thereof |
| TR201911272T4 (tr) | 2012-08-21 | 2019-08-21 | Janssen Pharmaceutica Nv | Paliperidon haptenleri. |
| PT2888593T (pt) | 2012-08-21 | 2018-12-12 | Janssen Pharmaceutica Nv | Anticorpos contra risperidona e utilizações dos mesmos |
| PT3333195T (pt) | 2012-08-21 | 2020-10-12 | Janssen Pharmaceutica Nv | Anticorpos contra a quetiapina e sua utilização |
| AU2016370853A1 (en) | 2015-12-17 | 2018-06-07 | Saladax Biomedical Inc. | Antibodies to quetiapine and use thereof |
| JP6949025B2 (ja) | 2015-12-17 | 2021-10-13 | ヤンセン ファーマシューティカ エヌ．ベー． | リスペリドンに対する抗体及びその使用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH569730A5 (cs) * | 1972-04-04 | 1975-11-28 | Wander Ag Dr A | |
| US3962248A (en) * | 1972-04-04 | 1976-06-08 | Sandoz, Inc. | Process for making 11-piperazino-diazepines, oxazepines, thiazepines and azepines |
| SU629879A3 (ru) * | 1974-11-26 | 1978-10-25 | Лилли Индастриз Лимитед, (Фирма) | Способ получени тиено(1,5) бензодиазепинов или их солей |
| US4061752A (en) * | 1975-08-06 | 1977-12-06 | Sandoz Ltd. | 6-Piperazino-11-methylene-dibenzazepines[b,e] |
| DK416476A (da) * | 1975-09-24 | 1977-03-25 | Sandoz Ag | Fremgangsmade til fremstilling af diazepinderivater |
| CH624682A5 (cs) * | 1976-11-10 | 1981-08-14 | Sandoz Ag | |
| US4761411A (en) * | 1983-05-18 | 1988-08-02 | Hoechst-Roussel Pharmaceuticals Inc. | Dihydrobenzopyrrolobenzodiazepines useful for treating pyschoses |
| GB9009229D0 (en) * | 1990-04-25 | 1990-06-20 | Lilly Industries Ltd | Pharmaceutical compounds |
-
1993
- 1993-05-26 EP EP93304102A patent/EP0582368B1/en not_active Expired - Lifetime
- 1993-05-26 NO NO931917A patent/NO305125B1/no not_active IP Right Cessation
- 1993-05-26 PT PT93304102T patent/PT582368E/pt unknown
- 1993-05-26 AT AT93304102T patent/ATE198891T1/de not_active IP Right Cessation
- 1993-05-26 CA CA002097016A patent/CA2097016A1/en not_active Abandoned
- 1993-05-26 DE DE69329887T patent/DE69329887T2/de not_active Expired - Fee Related
- 1993-05-26 AU AU39807/93A patent/AU668159B2/en not_active Ceased
- 1993-05-26 TW TW082104161A patent/TW268005B/zh active
- 1993-05-26 ES ES93304102T patent/ES2153373T3/es not_active Expired - Lifetime
- 1993-05-26 NZ NZ247703A patent/NZ247703A/en unknown
- 1993-05-26 DK DK93304102T patent/DK0582368T3/da active
- 1993-05-27 MX MX9303124A patent/MX9303124A/es not_active IP Right Cessation
- 1993-05-28 CZ CZ931024A patent/CZ282783B6/cs not_active IP Right Cessation
- 1993-05-28 CN CN93108212A patent/CN1043994C/zh not_active Expired - Fee Related
- 1993-05-28 FI FI932445A patent/FI101538B1/fi active
- 1993-05-28 IL IL10582793A patent/IL105827A/xx not_active IP Right Cessation
- 1993-05-28 HU HU9301579A patent/HU218278B/hu not_active IP Right Cessation
- 1993-05-28 MY MYPI93001036A patent/MY109943A/en unknown
- 1993-05-28 RU RU93005057A patent/RU2125574C1/ru active
- 1993-05-28 JP JP12642993A patent/JP3219541B2/ja not_active Expired - Fee Related
-
2001
- 2001-03-15 GR GR20010400431T patent/GR3035587T3/el not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| FI932445L (fi) | 1993-11-30 |
| IL105827A0 (en) | 1993-09-22 |
| NO931917L (no) | 1993-11-30 |
| FI101538B (fi) | 1998-07-15 |
| NO931917D0 (no) | 1993-05-26 |
| AU3980793A (en) | 1993-12-02 |
| CA2097016A1 (en) | 1993-11-30 |
| IL105827A (en) | 1997-02-18 |
| EP0582368A1 (en) | 1994-02-09 |
| DE69329887D1 (de) | 2001-03-01 |
| ATE198891T1 (de) | 2001-02-15 |
| NZ247703A (en) | 1995-07-26 |
| EP0582368B1 (en) | 2001-01-24 |
| HU9301579D0 (en) | 1993-09-28 |
| RU2125574C1 (ru) | 1999-01-27 |
| AU668159B2 (en) | 1996-04-26 |
| FI932445A0 (fi) | 1993-05-28 |
| CN1043994C (zh) | 1999-07-07 |
| MY109943A (en) | 1997-10-31 |
| ES2153373T3 (es) | 2001-03-01 |
| HUT66180A (en) | 1994-09-28 |
| PT582368E (pt) | 2001-05-31 |
| DK0582368T3 (da) | 2001-02-05 |
| HU218278B (en) | 2000-07-28 |
| FI101538B1 (fi) | 1998-07-15 |
| JP3219541B2 (ja) | 2001-10-15 |
| CZ282783B6 (cs) | 1997-10-15 |
| CZ102493A3 (en) | 1993-12-15 |
| MX9303124A (es) | 1993-11-01 |
| JPH0687862A (ja) | 1994-03-29 |
| DE69329887T2 (de) | 2001-05-23 |
| TW268005B (cs) | 1996-01-11 |
| CN1085903A (zh) | 1994-04-27 |
| GR3035587T3 (en) | 2001-06-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO305125B1 (no) | Farmas°ytiske forbindelser | |
| KR930703355A (ko) | 항생물질 ge2270 인자의 아미드 | |
| KR870700620A (ko) | 신규 약리학적 화합물 | |
| DK0674513T3 (da) | Retroviral protease-inhiberende forbindelser | |
| ES2054020T3 (es) | Compuestos biologicamente activos. | |
| EP0324387A3 (en) | Composition for treatment of ischemic disorder in organs | |
| IL110151A0 (en) | Amide and urea derivatives and pharmaceutical compositions containing the same | |
| ATE198888T1 (de) | Antifungizide trisubstituierte tetrahydrofurane | |
| SE8404065D0 (sv) | Novel biologically active compounds | |
| SE9100920D0 (sv) | New active compounds | |
| ATE117989T1 (de) | Prostaglandinanaloge enthaltende lipidemulsion. | |
| PT90034A (pt) | Processo para a preparacao de tetra-hidroimidazo-{1,4}benzodiazepina-2-onas | |
| DK607783D0 (da) | Nitroaliphatiske forbindelser | |
| DE3371627D1 (en) | Acetylsalicylic acid thioesters, a process for their preparation and pharmaceutical compositions containing them | |
| TW275629B (cs) | ||
| GB8823040D0 (en) | Organic compounds & their use as pharmaceuticals | |
| DE3867494D1 (de) | Fluor enthaltende vitamin-d2-derivate. | |
| ES2037825T3 (es) | Uso farmaceutico de tioeteres aromaticos. | |
| GB8823042D0 (en) | Organic compounds & their use as pharmaceuticals | |
| DK0826663T3 (da) | Alkynylaminosyrederivater og deres anvendelse som farmaceutiske forbindelser |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM1K | Lapsed by not paying the annual fees |
Free format text: LAPSED IN NOVEMBER 2002 |